Australia markets closed

Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
13.09+0.09 (+0.69%)
As of 10:19AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 7.52B
Enterprise value 7.54B
Trailing P/E 50.81
Forward P/E 51.02
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.01
Price/book (mrq)7.22
Enterprise value/revenue 4.74
Enterprise value/EBITDA 17.37

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 38.06%
S&P500 52-week change 317.24%
52-week high 316.69
52-week low 310.24
50-day moving average 314.09
200-day moving average 315.10

Share statistics

Avg vol (3-month) 3652
Avg vol (10-day) 3200
Shares outstanding 5579.41M
Implied shares outstanding 6581.08M
Float 8577.09M
% held by insiders 18.36%
% held by institutions 135.74%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.25
Forward annual dividend yield 41.94%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 33.12%
5-year average dividend yield 41.43
Payout ratio 4102.26%
Dividend date 3N/A
Ex-dividend date 425 June 2023
Last split factor 25:1
Last split date 303 Oct 2004

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 30 Mar 2023
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 15.83%
Operating margin (ttm)21.01%

Management effectiveness

Return on assets (ttm)9.63%
Return on equity (ttm)14.58%

Income statement

Revenue (ttm)1.58B
Revenue per share (ttm)2.73
Quarterly revenue growth (yoy)13.90%
Gross profit (ttm)938.4M
EBITDA 409.5M
Net income avi to common (ttm)250.3M
Diluted EPS (ttm)0.26
Quarterly earnings growth (yoy)-0.50%

Balance sheet

Total cash (mrq)121.5M
Total cash per share (mrq)0.21
Total debt (mrq)145.8M
Total debt/equity (mrq)8.31%
Current ratio (mrq)2.67
Book value per share (mrq)3.03

Cash flow statement

Operating cash flow (ttm)238.2M
Levered free cash flow (ttm)26.94M